Andra Ap Fonden Sarepta Therapeutics, Inc. Transaction History

Andra Ap Fonden

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$72.25 - $168.95 $93,925 - $219,634	-1,300 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$125.56 - $178.74 $25,112 - $35,748	-200 Reduced 13.33%	1,300 $222,000
Q3 2020 Nov 12, 2020	SELL	$127.12 - $172.34 $851,704 - $1.15 Million	-6,700 Reduced 81.71%	1,500 $211,000
Q2 2020 Aug 06, 2020	SELL	$93.0 - $171.7 $632,400 - $1.17 Million	-6,800 Reduced 45.33%	8,200 $1.32 Million
Q1 2020 May 13, 2020	BUY	$82.38 - $131.64 $1.24 Million - $1.97 Million	15,000 New	15,000 $1.47 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

Stay updated on Andra Ap Fonden with notifications on news.